{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:50:51Z","timestamp":1695505851128},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,5,19]],"date-time":"2008-05-19T00:00:00Z","timestamp":1211155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,5,19]],"date-time":"2008-05-19T00:00:00Z","timestamp":1211155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/bmt.2008.149","type":"journal-article","created":{"date-parts":[[2008,5,19]],"date-time":"2008-05-19T15:53:08Z","timestamp":1211212388000},"page":"281-282","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Post-transplant lymphoproliferative disease following reduced intensity conditioning transplants incorporating alemtuzumab"],"prefix":"10.1038","volume":"42","author":[{"given":"S W","family":"Bokhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Das-Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N H","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,19]]},"reference":[{"key":"BFbmt2008149_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.bmt.1701468","volume":"22","author":"IN Micallef","year":"1998","unstructured":"Micallef IN, Chhanabhai M, Gascoyne RD, Shepherd JD, Fung HC, Nantel SH et al. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience. Bone Marrow Transplant 1998; 22: 981\u2013987.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008149_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.bmt.1702477","volume":"26","author":"G Hale","year":"2000","unstructured":"Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N et al. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Bone Marrow Transplant 2000; 26: 69\u201376.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008149_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/10428190601059837","volume":"48","author":"JM Cohen","year":"2007","unstructured":"Cohen JM, Cooper N, Chakrabarti S, Thomson K, Samarasinghe S, Cubitt D et al. EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning. Leuk Lymphoma 2007; 48: 256\u2013269.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2008149_CR4","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","volume":"108","author":"CG Brunstein","year":"2006","unstructured":"Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874\u20132880.","journal-title":"Blood"},{"key":"BFbmt2008149_CR5","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V91.8.3079.3079_3079_3083","volume":"91","author":"G Hale","year":"1998","unstructured":"Hale G, Waldmann H . Risks of developing Epstein\u2013Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users. Blood 1998; 91: 3079\u20133083.","journal-title":"Blood"},{"key":"BFbmt2008149_CR6","first-page":"427","volume":"2","author":"Y Gazitt","year":"1987","unstructured":"Gazitt Y, Or R, Mumcuoglu M, Slavin S . Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells. Bone Marrow Transplant 1987; 2: 427\u2013433.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T10:08:12Z","timestamp":1648030092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,19]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BFbmt2008149"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.149","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,19]]},"assertion":[{"value":"19 May 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}